About Us

Organon Biosimilars prioritizes collaboration to help realize biosimilar goals

Organon brings the dedication you expect when working with a global biopharmaceutical company. With an increased focus on biosimilars and deep biologics expertise—we are ready to work with you.

Every company approaches your biosimilar experience differently. We at Organon believe your experience matters. Helping to navigate the complexities of biosimilar adoption is part of our commitment to the potential biosimilars can bring to the health care system. To achieve this, we stay updated with the evolving biosimilar landscape and strive to ensure you have the right information and resources at every step.

Our dedication to our customers defines us—not only through biosimilar adoption, but throughout the entire biosimilar experience. There are other approaches to biosimilars, but we believe that ethics, empathy, and commitment at the core will ultimately best serve all our stakeholders on the path toward value-driven change.

About Organon Biosimilars
Ready To Adopt Biosimilars?

Ready to get started?

Considering biosimilar adoption?

Biosimilars Roadmap—For Institutions

Roadmap for health care professionals for considering, implementing, and monitoring biosimilar adoption in an institution.

Biosimilars Roadmap - For Institutions

Biosimilars Roadmap—For Physicians

Roadmap for health care professionals for considering, implementing, and monitoring biosimilar adoption in a private practice setting.

Biosimilars Roadmap - For Physicians

Transitioning to Biosimilars Video

Three-minute video during which Chris Fourment, MD, clears up popular misconceptions regarding the transition of patients to biosimilars.

Transitioning to Biosimilars Video